Sarah Cannon Research Institute
John Michael Oehlschlaeger is a skilled financial professional with diverse experience in budgeting, credit analysis, and financial services. Currently serving as a Budget Analyst at Sarah Cannon Research Institute since March 2023, Oehlschlaeger previously held positions such as Credit Analyst and Credit Billing Specialist at Workwear Outfitters from December 2021 to March 2023, and Financial Services Representative at SmartBank from November 2020 to November 2021. Oehlschlaeger has also contributed to sales and operational roles at Bellhop and BDT Beverage, alongside experience as an Academic Chair for Lambda Chi Alpha Zete Phi Zeta. Oehlschlaeger earned a Bachelor of Finance in Finance and Financial Management Services from The University of Tennessee at Chattanooga in 2020.
Sarah Cannon Research Institute
Sarah Cannon Research Institute (SCRI) is one of the world’s leading oncology research organizations conducting community-based clinical trials. In 2022, SCRI formed a joint venture with former US Oncology Research to enhance clinical trial access and availability across the country. Focused on advancing therapies for patients over the last three decades, SCRI is a leader in drug development. It has conducted nearly 700 first-in-human clinical trials since its inception and contributed to pivotal research that has led to the majority of new cancer therapies approved by the FDA today. The combined research network brings together physicians who are actively accruing patients to clinical trials at more than 250 locations in 26 states across the US.